Valeos Pharma A/S: Financial statements 2023
CVR: 39696614
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,838,506 and a net result of DKK -16,533,984 compared with DKK -11,425,601 the year before. Equity in the 2023 report amounted to DKK -8,428,043. The company had 18 employees in the financial year.
- Gross Profit
- DKK -5,838,506
- Profit/Loss
- DKK -16,533,984
- Equity
- DKK -8,428,043
- Total Assets
- DKK 61,095,099
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5.8M | -16.5M | -8.4M | 18 |
| 2022 | - | -6.5M | -11.4M | 5.1M | 10 |
| 2021 | - | -3.4M | -6.4M | 16.5M | 7 |
| 2020 | - | -1.3M | -1.7M | -1.4M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Valeos Pharma A/S has published its annual report for 2022. Gross profit came to DKK -6,489,428, and the net result was DKK -11,425,601.
About Valeos Pharma A/S
Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.